129 related articles for article (PubMed ID: 10605071)
21. Possible steady-state concentrations of tetrahydroisoquinolines in brain after the consumption of ethanol.
Weiner H
Fed Proc; 1981 May; 40(7):2082-5. PubMed ID: 7227563
[TBL] [Abstract][Full Text] [Related]
22. Assay for the (R)- and (S)-enantiomers of salsolinols in biological samples and foods with ion-pair high-performance liquid chromatography using beta-cyclodextrin as a chiral mobile phase additive.
Deng Y; Maruyama W; Kawai M; Dostert P; Yamamura H; Takahashi T; Naoi M
J Chromatogr B Biomed Sci Appl; 1997 Feb; 689(2):313-20. PubMed ID: 9080316
[TBL] [Abstract][Full Text] [Related]
23. Dopamine-derived tetrahydroisoquinolines and Parkinson's disease.
Dostert P; Strolin Benedetti M; Della Vedova F; Allievi C; La Croix R; Dordain G; Vernay D; Durif F
Adv Neurol; 1993; 60():218-23. PubMed ID: 8420138
[TBL] [Abstract][Full Text] [Related]
24. N-methyl(R)salsolinol, a dopamine neurotoxin, in Parkinson's disease.
Naoi M; Maruyama W
Adv Neurol; 1999; 80():259-64. PubMed ID: 10410730
[No Abstract] [Full Text] [Related]
25. Modified electron-capture GLC assay for salsolinol in brain tissue.
O'Neill PJ; Rahwan RG
J Pharm Sci; 1977 Jun; 66(6):893-5. PubMed ID: 874802
[TBL] [Abstract][Full Text] [Related]
26. Rat brain salsolinol and blood-brain barrier.
Origitano T; Hannigan J; Collins MA
Brain Res; 1981 Nov; 224(2):446-51. PubMed ID: 7284853
[No Abstract] [Full Text] [Related]
27. Salsolinol and dopamine in rat medial basal hypothalamus after chronic ethanol exposure.
Myers WD; Mackenzie L; Ng KT; Singer G; Smythe GA; Duncan MW
Life Sci; 1985 Jan; 36(4):309-14. PubMed ID: 4038420
[TBL] [Abstract][Full Text] [Related]
28. A model to estimate the in vivo level of tetrahydroisoquinoline in brain during the consumption of ethanol.
Weiner H
Prog Clin Biol Res; 1982; 90():69-79. PubMed ID: 7111327
[No Abstract] [Full Text] [Related]
29. In vivo formation of salsolinol induced by high acetaldehyde concentration in rat striatum employing microdialysis.
Jamal M; Ameno K; Kubota T; Ameno S; Zhang X; Kumihashi M; Ijiri I
Alcohol Alcohol; 2003; 38(3):197-201. PubMed ID: 12711651
[TBL] [Abstract][Full Text] [Related]
30. Effect of ethanol on (R)- and (S)-salsolinol, salsoline, and THP in the nucleus accumbens of AA and ANA rats.
Sällström Baum S; Hill R; Kiianmaa K; Rommelspacher H
Alcohol; 1999; 18(2-3):165-9. PubMed ID: 10456568
[TBL] [Abstract][Full Text] [Related]
31. Absence of formation of brain salsolinol in ethanol-dependent mice.
O'Neill PJ; Rahwan RG
J Pharmacol Exp Ther; 1977 Feb; 200(2):306-13. PubMed ID: 557108
[TBL] [Abstract][Full Text] [Related]
32. Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometry.
Niwa T; Maruyama W; Nakahara D; Takeda N; Yoshizumi H; Tatematsu A; Takahashi A; Dostert P; Naoi M; Nagatsu T
J Chromatogr; 1992 Jul; 578(1):109-15. PubMed ID: 1400775
[TBL] [Abstract][Full Text] [Related]
33. Estimation of the in vivo concentration of salsolinol and tetrahydropapaveroline in rat brain after the administration of ethanol.
Weiner H
Subst Alcohol Actions Misuse; 1980; 1(3):317-22. PubMed ID: 7347923
[TBL] [Abstract][Full Text] [Related]
34. Salsolinol in the brain.
Kemperman CJ
Lancet; 1982 Apr; 1(8278):972. PubMed ID: 6122809
[No Abstract] [Full Text] [Related]
35. Selective 7-0-methylation of salsolinol in rat brain and heart in vivo.
Bail M; Miller S; Cohen G
Life Sci; 1980 Jun; 26(24):2051-60. PubMed ID: 7392818
[No Abstract] [Full Text] [Related]
36. Uptake of the dopaminergic neurotoxin, norsalsolinol, into PC12 cells via dopamine transporter.
Maruyama Y; Suzuki Y; Kazusaka A; Fujita S
Arch Toxicol; 2001 Jun; 75(4):209-13. PubMed ID: 11482518
[TBL] [Abstract][Full Text] [Related]
37. Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson's disease brain.
DeCuypere M; Lu Y; Miller DD; LeDoux MS
J Neurochem; 2008 Dec; 107(5):1398-413. PubMed ID: 19013830
[TBL] [Abstract][Full Text] [Related]
38. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
Naoi M; Maruyama W; Nagy GM
Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
[TBL] [Abstract][Full Text] [Related]
39. Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease.
Scholz J; Klingemann I; Moser A
J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):634-6. PubMed ID: 15026514
[TBL] [Abstract][Full Text] [Related]
40. A systematic regional study of brain salsolinol levels during and immediately following chronic ethanol ingestion in rats.
Matsubara K; Fukushima S; Fukui Y
Brain Res; 1987 Jun; 413(2):336-43. PubMed ID: 3607483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
